Industry Profile
Cardiovascular Research and Therapeutics
Target researchers — Cardiologists, physiologists, and molecular biologists specializing in lipid metabolism, heart failure mechanisms, cardiac fibrosis, atherosclerosis, arrhythmia genetics, and gene-based cardiovascular therapies
Cardiovascular therapeutics address the leading cause of global mortality through lipid-lowering agents, heart failure drugs, and emerging gene-based interventions. Academic cardiovascular research groups generate foundational IP in PCSK9 biology, cardiac metabolism, and gene therapy delivery that biotech and pharma companies license for IND-enabling programs.
Key Companies
Use Cases
PCSK9 and lipid metabolism target licensing
Heart failure mechanism co-development
Cardiac biomarker platform partnerships
Gene editing cardiovascular therapy IP
Patient cohort and imaging data access
CRISPR-based cardiology program consulting
Free to browse · subscribe to unlock the full dataset
See the full dataset.
Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.
Sign Up Free →